Jasmine Kway insider trades

Open-market stock purchases and sales by Jasmine Kway, CEO - Singapore Volition at Volitionrx Ltd, from SEC Form 4 filings since Apr 13, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +16%.

Recent trades

DateStockTradeValue
Feb 26, 2026VNRX Volitionrx LtdBought (not open market)—
Jan 22, 2026VNRX Volitionrx LtdBought (not open market)—

Companies traded

  • VNRX Volitionrx Ltd: 1 buy, last Feb 26, 2026

Get free alerts when Jasmine Kway files a new trade →